Please login to the form below

FujiFilm

This page shows the latest FujiFilm news and features for those working in and with pharma, biotech and healthcare.

UK agrees on COVID-19 vaccine deals with J&J and Novavax

Novavax will also conduct a phase 3 clinical trial of its vaccine candidate with support from the UK’s National Institute for Health Research (NIHR), and has partnered with FUJIFILM Diosynth

Latest news

Bayer takes control of BlueRock stem cell joint venture

The venture unit followed that a few weeks later with a $215m investment in Century Therapeutics, with additional backing for the company coming from Versant and Fujifilm Cellular Dynamics.
Pfizer closes on EU approval of lung cancer drug Vizimpro

The two new biosimilars will join products from Amgen, Samsung Bioepis/Biogen, Mylan/Fujifilm Kyowa Kirin, and Novartis’ Sandoz unit in an assault on AbbVie’s market share for the
NHS says Humira biosimilar deal will save £300m

s Cyltezo and Mylan’s Hulio, the latter sublicensed from Japan’s Fujifilm Kyowa Kirin.
First Humira biosimilars reach EU market

Copycat versions of the TNF inhibitor from Amgen, Samsung Bioepis/Biogen, Mylan/Fujifilm Kyowa Kirin, and Novartis’ Sandoz unit are starting to become available in their first EU markets now that ... Imraldi. There is no word yet on the roll-out
Fujifilm expands biopharma development and manufacturing business

Company invests 3.2bn yen in US and UK sites. Fujifilm Corporation is investing 3.2bn yen ($28m) to expand the biopharmaceutical manufacturing and development operations of its contract development and ... More specifically, the new investment will

More from news
Approximately 2 fully matching, plus 7 partially matching documents found.

Latest Intelligence

Deal Watch March 2016

The sale of the diagnostic imaging business was believed to be hotly contested by Fujifilm and Konica Minolta, with Canon the successful bidder.
Pharma deals in July 2015

Still in Japan, a week later AZ agreed a joint venture with Fujifilm Kyowa Kirin Biologics for the development and commercialisation of a biosimilar version of bevacizumab (Avastin) in phase I ... Fujifilm Kyowa KirinBiologics will transfer the product
Pharma deals in March 2015

The high level of interest in cell therapies generally may have been one reason why Fujifilm acquired Cellular Dynamics for $307m at an eye watering share price premium of 108%. ... Fujifilm expects to achieve significant synergies. Checkpoint inhibitors

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

BIA elects six new board members

The remaining new appointments are Stephen Taylor of Fujifilm Diosynth Biotechnologies; Donna Hackett, director of life sciences consultancy firm KDH BioManagement; and Tim Watts, chief financial officer of Oxford BioMedica.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Madmicrobe Studios

MadMicrobe is an award-winning team of animators and science experts creating photo real life-science animation content for the healthcare and...

Latest intelligence

Could formulary intelligence be your brand differentiator?: Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
How COVID-19 is accelerating the threat of antimicrobial resistance: Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping: Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...